BamSEC and AlphaSense Join Forces
Learn More

ARS Pharmaceuticals Inc. – Indentures

NASDAQ: SPRY    
Share price (8/6/26): $5.55    
Market cap (8/6/26): $551 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.8
from S-3ASR 55 pages ARS Pharmaceuticals, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.7
from S-3ASR 18 pages ARS Pharmaceuticals, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as Of
12/34/56
EX-4.5
from S-3ASR 20 pages ARS Pharmaceuticals, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as Of
12/34/56
EX-4.4
from S-3ASR 20 pages ARS Pharmaceuticals, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as Of
12/34/56
EX-4
from 10-K 5 pages Description of Common Stock
12/34/56
EX-4.1
from 8-K 14 pages Warrant to Purchase Preferred Stock
12/34/56
EX-4.8
from S-3 19 pages Silverback Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Silverback Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3 20 pages Silverback Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Silverback Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3 20 pages Silverback Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Silverback Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from S-3 55 pages Silverback Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Debt Securities
12/34/56
EX-4.6
from 10-K 4 pages Description of Common Stock
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.4
from S-1 12 pages Warrant to Purchase Common Stock
12/34/56
EX-4.3
from S-1 12 pages Warrant to Purchase Common Stock
12/34/56
EX-4.2
from S-1 51 pages Silverback Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.4
from DRS 12 pages Warrant to Purchase Common Stock
12/34/56
EX-4.3
from DRS 12 pages Warrant to Purchase Common Stock
12/34/56
EX-4.2
from DRS 51 pages Silverback Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56